Sangamo Biosciences's market cap is currently $166.24M. The company's EPS TTM is $-0.08; its P/E ratio is ―; Sangamo Biosciences is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
